Depo-Provera and Brain Tumors: What You Need to Know

March 10, 2025/attorney/Depo-Provera

Does Depo-Provera Increase the Risk of Brain Tumors?

Depo-Provera, a widely used injectable birth control, has come under scrutiny due to its potential link to meningiomas-a type of brain tumor. Research suggests that prolonged exposure to medroxyprogesterone acetate, the active ingredient in Depo-Provera, may significantly increase the risk of developing these tumors. While meningiomas are typically non-cancerous, they can still lead to severe neurological complications.

A recent study published in The BMJ found that women who used Depo-Provera for more than one year faced a 5.6-fold increased risk of developing intracranial meningiomas. The study examined medical records of thousands of women and identified a strong correlation between long-term use of the drug and meningioma development. Given the widespread use of Depo-Provera, these findings have raised concerns about its safety.

Additionally, some European countries have already implemented restrictions on progestogen-based contraceptives due to their association with meningiomas. Yet, in the United States, Pfizer-the manufacturer of Depo-Provera-has not updated its warning labels to reflect these risks. This has led to growing legal battles against the pharmaceutical giant.

Understanding Meningiomas and Their Connection to Depo-Provera

Meningiomas are tumors that form in the meninges, the protective layers surrounding the brain and spinal cord. While most are benign, they can cause severe symptoms if they grow large enough to press on brain tissue, nerves, or blood vessels.

Symptoms of meningiomas may include:

Persistent headaches
Vision problems or partial blindness
Seizures
Hearing loss or ringing in the ears
Memory issues and cognitive decline
Weakness or numbness in the limbs

Medical researchers believe that hormones play a significant role in meningioma development. Since Depo-Provera contains a synthetic progestin, it may promote abnormal cell growth in the meninges, increasing the risk of tumor formation. This connection is particularly concerning for women who use Depo-Provera long-term, as their cumulative exposure to progestins is much higher.

Scientific Studies Confirming the Link Between Depo-Provera and Brain Tumors

Over the past decade, multiple studies have examined the connection between Depo-Provera and meningiomas. While early research raised suspicions, more recent large-scale studies have confirmed that prolonged use of Depo-Provera significantly increases the risk of developing these brain tumors.

One of the most notable studies, published in The BMJ in March 2024, found that women who used Depo-Provera for more than a year had a 5.6-fold increased risk of meningiomas compared to those who did not use the drug. The study analyzed thousands of medical records and found that the longer a woman used Depo-Provera, the higher her risk.

Another study, conducted by researchers in France, examined over 117,000 cases of meningiomas and found that women exposed to injectable medroxyprogesterone acetate (the active ingredient in Depo-Provera) had a 53% increased likelihood of developing these tumors. This research led some European health agencies to restrict the use of the drug, but Pfizer has yet to make similar changes in the U.S.

Other key findings from scientific research include:

Women with a history of prolonged Depo-Provera use were more likely to develop multiple meningiomas.
Tumors in Depo-Provera users were often larger and required surgical intervention.
Some cases of meningiomas regressed after discontinuation of Depo-Provera, suggesting a hormonal influence on tumor growth.

Despite these alarming findings, Pfizer has not updated the drug’s warning labels in the U.S., leading to increased scrutiny and legal challenges.

Legal Actions Against Pfizer for Failing to Warn About Tumor Risks

As evidence of Depo-Provera’s dangers mounts, legal actions against Pfizer are increasing. Many women who have developed meningiomas after using Depo-Provera are filing lawsuits, claiming that the manufacturer failed to properly warn them of the risks.

In early 2025, more than 20 lawsuits were consolidated into multidistrict litigation (MDL) in the Northern District of Florida. These cases argue that Pfizer:

Negligently marketed Depo-Provera without adequate warnings.
Failed to conduct sufficient long-term safety studies.
Ignored scientific evidence linking Depo-Provera to meningiomas.
Did not update U.S. warning labels despite European restrictions on the drug.

One of the lead plaintiffs in the MDL, a woman from Missouri, underwent multiple brain surgeries after using Depo-Provera for nearly two decades. Her lawsuit claims that Pfizer knew about the risks but deliberately concealed them.

Additional class-action lawsuits are also emerging, demanding that Pfizer provide medical monitoring for women who have used Depo-Provera for extended periods. These lawsuits seek compensation for medical expenses, lost wages, and emotional distress suffered by those affected.

As litigation moves forward, attorneys expect Pfizer to argue that the FDA’s approval of Depo-Provera shields them from liability. However, previous lawsuits against drug manufacturers have shown that failure to warn consumers of known risks can lead to significant legal consequences.

What to Do If You Have Used Depo-Provera and Are Experiencing Symptoms

If you have used Depo-Provera and are experiencing neurological symptoms, it is crucial to seek medical attention immediately. Meningiomas can grow slowly, but if left untreated, they can cause severe complications, including permanent brain damage.

Warning signs of a possible meningioma include:

Frequent and persistent headaches
Blurred vision or double vision
Seizures or sudden neurological issues
Hearing loss or ringing in the ears
Memory problems or confusion
Difficulty with coordination or balance

Steps to take if you suspect a Depo-Provera-related brain tumor:

Schedule a medical evaluation: An MRI or CT scan can detect meningiomas.
Request a full medical history review: If you have been using Depo-Provera for an extended period, inform your doctor about the possible risk.
Consult with a legal team: If you are diagnosed with a meningioma, you may be eligible to file a lawsuit against Pfizer to seek compensation for medical costs and damages.

At Alonso Krangle, LLP, our attorneys are actively representing women who have suffered severe health consequences due to Depo-Provera. If you or a loved one has been affected, we encourage you to call us at [PHONE] for a free case evaluation.

Depo-Provera Treatment Options and Medical Considerations

For women diagnosed with a meningioma potentially linked to Depo-Provera, medical intervention varies based on the tumor’s size, location, and severity of symptoms. Since meningiomas are typically slow-growing, doctors may recommend different approaches depending on individual circumstances.

Common treatment options include:

Observation: If the tumor is small and not causing symptoms, doctors may opt for regular monitoring through MRI scans.
Surgical Removal: In cases where the tumor is large or pressing on critical brain structures, surgery may be necessary to remove it.
Radiation Therapy: For tumors that cannot be completely removed through surgery, radiation therapy may be used to shrink or slow the tumor’s growth.
Hormonal Therapy Considerations: Some studies suggest that discontinuing progesterone-based treatments, such as Depo-Provera, may reduce the risk of further tumor growth.

Women diagnosed with meningiomas should discuss their treatment options with a neurologist or neurosurgeon to determine the best course of action. Additionally, it is essential to inform medical providers about past or current Depo-Provera use to help guide treatment decisions.

How to Protect Your Legal Rights If You Were Harmed by Depo-Provera

Women who have developed meningiomas after using Depo-Provera may be eligible for financial compensation. Given the growing evidence linking Depo-Provera to brain tumors, lawsuits against Pfizer are gaining traction.

If you believe your meningioma was caused by Depo-Provera, follow these steps:

Gather Medical Records: Obtain documentation of your Depo-Provera use and any medical diagnoses related to brain tumors.
Consult a Legal Professional: Speak with a pharmaceutical injury attorney who understands Depo-Provera litigation and can assess your case.
Join a Lawsuit or File an Individual Claim: Depending on your situation, you may be able to join a class-action lawsuit or file an individual lawsuit against Pfizer.

Potential compensation may cover:

Medical expenses (surgery, radiation, long-term care)
Lost wages due to inability to work
Pain and suffering
Emotional distress
Loss of quality of life

The legal community expect more cases to be filed as awareness of the risks grows. If you or a loved one has been affected, taking action now can help ensure your rights are protected.

Contact Our Legal Team for a Free Case Review

The growing body of research linking Depo-Provera to meningiomas has raised serious concerns about the safety of this widely used birth control injection. While some regulatory agencies in Europe have taken steps to warn women about the risks, Pfizer has yet to make similar changes in the United States.

If you or someone you love has been diagnosed with a brain tumor after using Depo-Provera, you deserve answers. You may have the right to pursue a legal claim against Pfizer for failing to warn consumers about these dangers.

At Alonso Krangle, LLP, we are committed to helping victims of dangerous drugs fight for justice. Our legal team can help you understand your options, evaluate your case, and determine whether you qualify for compensation.

Call [PHONE] or fill out our free case evaluation form today. We will review your case at no cost and guide you through the legal process.

Resources:

attorney

Speak with An Attorney

Submit This Form or Call 800-403-6191

SE HABLA ESPAÑOL